iRhythm Holdings Inc.
Last updated September 27, 2026
Organization details
- Legal name
- iRhythm Holdings Inc.
- Former names
- IRhythm Technologies, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Headquarters city
- San Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- IRTC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001388658
- EIN
- 41-3421287
Board of directors
-
Abhijit Y. Talwalkar · DirectorSince 2023
-
Brian B. Yoor · DirectorSince 2023
-
Bruce G. Bodaken · DirectorSince 2023
-
Jason H. Patten · DirectorSince 2026
-
Karen K. Mcginnis · DirectorSince 2025
-
Karen Ling · DirectorSince 2023
-
Kevin C. Oboyle · DirectorSince 2025
-
Mark J. Rubash · DirectorSince 2023
-
Merz Cathleen Noel Bairey · DirectorSince 2023
-
Mojdeh Poul · DirectorSince 2023
-
Quentin S. Blackford · Director · President and CEOSince 2023
-
Ralph Snyderman · DirectorSince 2023
Chief executives
Quentin S. Blackford
· President and CEO
Dates unknown
Director election results
Annual meeting of May 27, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
74.1%
-
95.6%
-
99.6%
-
99.8%
-
99.9%
-
99.9%
-
99.9%
-
99.9%
Board connections
7 of this board's directors also sit on 12 other boards.
- via Mojdeh Poul and Quentin S. Blackford
- via Karen K. Mcginnis and Quentin S. Blackford
- via Karen K. Mcginnis
- via Abhijit Y. Talwalkar
- via Karen Ling
- via Kevin C. Oboyle
- via Mojdeh Poul
- via Mark J. Rubash
- via Abhijit Y. Talwalkar
- via Kevin C. Oboyle
- via Mojdeh Poul
- via Abhijit Y. Talwalkar
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $56,892
- 1 purchase by 1 insider
- Sold, last 12 months
- $29,640,277
- 66 sales by 12 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Wilson Daniel G. Officer (Chief Financial Officer) | Open-market sale | −773 | $121.83 | $94,175 |
| Aug 10, 2026 | Quentin S. Blackford Director, Officer (President and CEO) | Open-market sale | −26,859 | $124.65 | $3,348,012 |
| Aug 10, 2026 | Murphy Patrick Michael Officer (CBO and CLO) | Open-market sale | −7,093 | $124.65 | $884,156 |
| Aug 10, 2026 | Patterson Chad Officer (CHIEF COMM & PRODUCT OFFICER) | Open-market sale | −7,093 | $124.65 | $884,170 |
| Aug 10, 2026 | Shrishrimal Sumi Officer (EVP, Chief Risk Officer) | Open-market sale | −5,372 | $124.65 | $669,641 |
| Aug 10, 2026 | Turakhia Minang Officer (CHIEF MED/SCI OFCR EVP ADVTECH) | Open-market sale | −7,093 | $124.65 | $884,151 |
| Aug 7, 2026 | Quentin S. Blackford Director, Officer (President and CEO) | Grant or award | +48,534 | — | — |
| Aug 7, 2026 | Murphy Patrick Michael Officer (CBO and CLO) | Grant or award | +13,589 | — | — |
| Aug 7, 2026 | Patterson Chad Officer (CHIEF COMM & PRODUCT OFFICER) | Grant or award | +13,589 | — | — |
| Aug 7, 2026 | Shrishrimal Sumi Officer (EVP, Chief Risk Officer) | Grant or award | +9,706 | — | — |
| Aug 7, 2026 | Turakhia Minang Officer (CHIEF MED/SCI OFCR EVP ADVTECH) | Grant or award | +13,589 | — | — |
| Aug 3, 2026 | Patterson Chad Officer (CHIEF COMM & PRODUCT OFFICER) | Open-market sale | −2,712 | $122.12 | $331,192 |
| Aug 3, 2026 | Rodda Julianne Officer (EVP, CHIEF PEOPLE OFFICER) | Open-market sale | −2,112 | $122.12 | $257,919 |
| Aug 3, 2026 | Smith Mervin Officer (EVP Strategic Business Ops) | Open-market sale | −617 | $122.12 | $75,349 |
| Jul 2, 2026 | Freeman Sean Clinton Officer (EVP, Strategy & Corp Devt) | Open-market sale | −918 | $124.71 | $114,484 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.